Literature DB >> 11926378

Diagnosis, characterisation and evaluation of treatment response of frostbite using pertechnetate scintigraphy: a prospective study.

Aseem Bhatnagar1, B B Sarker, Krishan Sawroop, M K Chopra, Noaline Sinha, Ravi Kashyap.   

Abstract

No large prospective study is available on use of a radionuclide method to assess frostbite and its response to conservative treatment. Recently, a large retrospective study using two-phase bone scintigraphy suggested that non-uptake (or low uptake) in frostbite lesions in the blood pool or bone phase had a strong correlation with the subsequent need for amputation. In the present study, we performed early blood pool scintigraphy with technetium-99m pertechnetate in 20 patients (10-180 days after frostbite injury; 71 clinical lesions) referred for a topical treatment protocol for mild to moderately severe frostbite, and in 22 asymptomatic controls. The aims of the study were to define the "normal" microcirculation of the hands and feet, to characterise the appearances of frostbite lesions on scintigraphy and correlate these with the clinical presentation, and to evaluate the usefulness of scintigraphy for assessing the treatment response. Six patients were "fresh", 12 had been undergoing conservative treatment (topical homeopathic) for several weeks and two had permanent fibrotic hand phalanges. Nine patients on treatment underwent serial scintigraphy a total of 22 times. Eleven patients were imaged only once, including the two with permanent fixed defects. Three distinct physiological microcirculation patterns were evident in control hands or feet: right- or left-handedness (seven subjects), subclinical inflammatory foci correlating with callosity or pressure points (36 lesions) and distinctly increased pooling of radiotracer at the thenar or hypothenar region (eight subjects). In frostbite patients, 128 lesions (48 inflammatory, 80 ischaemic) were seen on the scan. This number included all 71 lesions identified clinically, the rest being subclinical. Subclinical frostbite lesion as an entity has not been described previously. Microvasculature of normal muscle groups (in the hands, elbow or feet) was shown on scintigraphy to improve after topical treatment. The treatment resulted in improved or normalised perfusion scan in 25 of 45 ischaemic segments with matching clinical improvement, and reduction or normalisation of uptake in inflammatory lesions (n=30). The data confirm the vasodilator and anti-inflammatory action of the topical preparation, and the sensitivity of the radionuclide method in monitoring treatment response. In contrast to the previous findings that non-uptake on a scan performed 2 or more weeks after exposure correlates with the need for amputation, none of the 80 ischaemic lesions in our series required amputation while 60% showed improvement or normalisation in microvascular blood flow even though they were 10-180 days old. Our findings suggest that moderate to severe frostbite lesion can be classified as having infarcted, ischaemic or hibernating (viable) tissue, similar to the classification employed when using myocardial scintigraphy. Absence of uptake even after the initial 10 days does not necessarily indicate infarction and the need for amputation as many such lesions retain potential for vasodilation and recovery.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11926378     DOI: 10.1007/s00259-001-0658-4

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  9 in total

1.  Early detection of microcirculatory perfusion changes with a high resolution, real time laser Doppler imaging camera--frostbite case study.

Authors:  Paolo Erba; Pascal Harbi; Tyler Thacher; Axel Pries; Giuseppe Ambrosio; Wassim Raffoul
Journal:  BMJ Case Rep       Date:  2011-09-19

Review 2.  Frostbite: Spectrum of Imaging Findings and Guidelines for Management.

Authors:  John D Millet; Richard K J Brown; Benjamin Levi; Casey T Kraft; Jon A Jacobson; Milton D Gross; Ka Kit Wong
Journal:  Radiographics       Date:  2016-08-05       Impact factor: 5.333

3.  "Growing pains" in children are not associated with changes in vascular perfusion patterns in painful regions.

Authors:  Philip J Hashkes; Miguel Gorenberg; Victor Oren; Orit Friedland; Yosef Uziel
Journal:  Clin Rheumatol       Date:  2004-11-26       Impact factor: 2.980

Review 4.  The utility of bone scintigraphy with SPECT/CT in the evaluation and management of frostbite injuries.

Authors:  Matthew S Manganaro; John D Millet; Richard Kj Brown; Benjamin L Viglianti; Daniel J Wale; Ka Kit Wong
Journal:  Br J Radiol       Date:  2018-11-01       Impact factor: 3.039

Review 5.  Evaluation of bone viability.

Authors:  Isabel Roca; Ignasi Barber; Cesar G Fontecha; Francisco Soldado
Journal:  Pediatr Radiol       Date:  2013-03-24

6.  Predictive value of 99mTc-sestamibi scintigraphy for healing of extremity amputation.

Authors:  Ali Sarikaya; Husamettin Top; A Cemal Aygit; Erol Benlier; Yasin Unal
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-07-29       Impact factor: 10.057

7.  Role of 99mTc MDP Bone Scan in Delineation of Ischaemic Zone in Cases of Severe Frostbite.

Authors:  Arun Ravi John; Anurag Jain; Braj Kishore; Aniruddha G Pandit
Journal:  Indian J Nucl Med       Date:  2017 Jul-Sep

8.  Comparative Study of Subcutaneous and Orthotopic Mouse Models of Prostate Cancer: Vascular Perfusion, Vasculature Density, Hypoxic Burden and BB2r-Targeting Efficacy.

Authors:  Wenting Zhang; Wei Fan; Satyanarayana Rachagani; Zhengyuan Zhou; Subodh M Lele; Surinder K Batra; Jered C Garrison
Journal:  Sci Rep       Date:  2019-07-31       Impact factor: 4.379

9.  Ischemic Muscle Necrosis of Lower Extremities in Peripheral Arterial Disease: The Impact of 99mTc-MDP Scintigraphy on Patient Management.

Authors:  Donatas Jocius; Donatas Vajauskas; Arminas Skrebunas; Marijus Gutauskas; Algirdas Edvardas Tamosiunas
Journal:  Medicina (Kaunas)       Date:  2019-11-28       Impact factor: 2.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.